Areas of Confusion in Oncology
Reviews
- Low-Risk Papillary Thyroid Cancer: Treatment Options and Patient Perceptions
- Can Risk-Adapted Treatment Recommendations Replace the ‘One Size Fits All’ Approach for Early-Stage Thyroid Cancer Patients?
- Prophylactic Central Lymph Node Dissection: Continued Controversy
Lymphoma
Reviews
- Relapsed/Refractory Diffuse Large B-cell Lymphoma: On the Threshold of New Therapies
- Looking Back (and Ahead) at Salvage Treatment for Non‑Hodgkin Lymphoma
Prostate Cancer
Reviews
- LHRH Antagonists vs LHRH Agonists: Which Is More Beneficial in Prostate Cancer Therapy?
- Is There a Role for LHRH Antagonists in Prostate Cancer?
- Important Considerations in LHRH Antagonist Therapy for Prostate Cancer
Commentary
Announcements
- Phase IIIB Trial of Intermittent Degarelix Therapy Launched
- FDA Fast-Tracks Talactoferrin/Sunitinib for Renal Cell Carcinoma
- ACLU Challenges Patents on Breast Cancer Genes
Reports From ASCO
- Maintenance Therapy With Pemetrexed(Drug information on pemetrexed) Improves Overall Survival in Advanced NSCLC
- PARP Inhibitors Show Promise for Hard-to-Treat Breast Cancers
- Therapeutic Cancer Vaccine Significantly Prolongs Disease-Free Survival for Follicular Lymphoma
- Vaccine Improves Response Rate and Extends Progression-Free Survival in Metastatic Melanoma
Integrative Oncology
